BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29665941)

  • 41. Genetics and diffuse large B-Cell lymphoma.
    Niroula R; Butera J
    R I Med J (2013); 2015 Nov; 98(11):23-6. PubMed ID: 26517251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of circulating lncRNAs in B-cell neoplasms.
    Isin M; Ozgur E; Cetin G; Erten N; Aktan M; Gezer U; Dalay N
    Clin Chim Acta; 2014 Apr; 431():255-9. PubMed ID: 24583225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma.
    Zhao S; Fang S; Liu Y; Li X; Liao S; Chen J; Liu J; Zhao L; Li H; Zhou W; Shen W; Dong X; Xiang R; Wang L; Zhao Y
    Oncotarget; 2017 May; 8(21):34374-34386. PubMed ID: 28423735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Progress of study on survivin in diffuse large B-cell lymphoma--review].
    Dou HJ; Hu JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1487-90. PubMed ID: 19099670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNAs in B-cell malignancies: a comprehensive overview.
    Nobili L; Ronchetti D; Taiana E; Neri A
    Oncotarget; 2017 Sep; 8(36):60605-60623. PubMed ID: 28947998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNAs: key players and novel insights into cervical cancer.
    Peng L; Yuan X; Jiang B; Tang Z; Li GC
    Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular pathogenesis of diffuse large B-cell lymphoma.
    Lossos IS
    J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma.
    Kim SH; Kim SH; Yang WI; Kim SJ; Yoon SO
    Oncotarget; 2017 May; 8(19):31305-31317. PubMed ID: 28412742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.
    Decruyenaere P; Offner F; Vandesompele J
    Exp Hematol Oncol; 2021 Feb; 10(1):13. PubMed ID: 33593440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors.
    Ma Z; Huang H; Xu Y; He X; Wang J; Hui B; Ji H; Zhou J; Wang K
    Onco Targets Ther; 2017; 10():4711-4717. PubMed ID: 29026319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances and Challenges in the Investigation of Metastasis in Diffuse Large B-Cell Lymphoma.
    Chen Y; Jiang L; Liu L; Ruan M; Zhou Z; Yang M; Xia L
    Mini Rev Med Chem; 2022; 22(22):2808-2812. PubMed ID: 35593342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serologic detection of diffuse large B-cell lymphoma-associated antigens.
    Liggins AP; Guinn BA; Hatton CS; Pulford K; Banham AH
    Int J Cancer; 2004 Jul; 110(4):563-9. PubMed ID: 15122589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas.
    Hershkovitz-Rokah O; Geva P; Salmon-Divon M; Shpilberg O; Liberman-Aronov S
    Oncotarget; 2018 Jan; 9(8):7928-7941. PubMed ID: 29487703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas.
    Bai M; Skyrlas A; Agnantis NJ; Kamina S; Papoudou-Bai A; Kitsoulis P; Kanavaros P
    Anticancer Res; 2005; 25(1A):347-62. PubMed ID: 15816558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
    Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
    Fayda M; Isin M; Tambas M; Guveli M; Meral R; Altun M; Sahin D; Ozkan G; Sanli Y; Isin H; Ozgur E; Gezer U
    Tumour Biol; 2016 Mar; 37(3):3969-78. PubMed ID: 26482616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
    Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
    Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Gossypium hirsutum long non-coding RNAs (lncRNAs) under salt stress.
    Deng F; Zhang X; Wang W; Yuan R; Shen F
    BMC Plant Biol; 2018 Jan; 18(1):23. PubMed ID: 29370759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.